FDA Adverse Event Malfunction Summary report: N

BINAXNOW¿ COVID-19 ANTIGEN SELF TEST

MDR report key: 15121020 · Received July 28, 2022

Report

Report Number
1221359-2022-03683
Event Type
Malfunction
Date Received
July 28, 2022
Date of Event
July 8, 2022
Report Date
August 12, 2022
Manufacturer
ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
Product Code
QKP
UDI-DI
00811877011408
PMA / PMN Number
EUA210264
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
OTHER
Health Professional
N

Narratives

Additional Manufacturer Narrative · 0

THE INVESTIGATION IS STILL IN PROGRESS. A SUPPLEMENTAL REPORT WILL BE PROVIDED AFTER COMPLETION. PLEASE REFERENCE 1221359-2022-03681.

Additional Manufacturer Narrative · 0

THIS SUPPLEMENTAL REPORT IS BEING SUBMITTED TO PROVIDE THE INVESTIGATION CONCLUSION. TESTING WAS PERFORMED AT ABBOTT DIAGNOSTICS SCARBOROUGH, INC. ON RETAINED KIT LOT 202644 WITH INTERNAL POSITIVE QUALITY CONTROL SAMPLES AND NEGATIVE QUALITY CONTROL SWABS. ALL TEST RESULTS WERE VALID AND PERFORMED AS EXPECTED. ADDITIONALLY, THE MANUFACTURING RECORDS AND QUALITY CONTROL RELEASE TESTING WAS REVIEWED FOR TEST KIT PART NUMBER 195-160/ LOT 202644 AND TEST BASE PART NUMBER 195-430H/ LOT 197668. THE LOT MET THE REQUIRED RELEASE SPECIFICATIONS. A REVIEW OF THE COMPLAINTS REPORTED AS FALSE POSITIVE PATIENT RESULTS (CONFIRMED AND UNCONFIRMED, CONFLICTING RESULTS) RELATED TO KIT LOT 202644 SHOWED THAT THE COMPLAINT RATE IS (B)(6). ABBOTT DIAGNOSTICS SCARBOROUGH WAS UNABLE TO DETERMINE THE EXACT ROOT CAUSE OF THE REPORTED ISSUE; HOWEVER, IT COULD POSSIBLY BE RELATED TO ISSUES INCLUDING THE SELF-TEST USER PERFORMANCE, INTERPRETATION OF THE RESULT, OR THE SPECIFIC PATIENT SAMPLE.

Description of Event or Problem · 0

THE CONSUMER REPORTED THREE (3) FALSE POSITIVE RESULTS WITH THE BINAX NOW COVID-19 ANTIGEN SELF TEST (LOT NUMBER 202644) ON VARIOUS DATES IN (B)(6) 2022. THIS REPORT CAPTURES TEST THREE (3) OF THREE (3). THE CONSUMER REPORTED A FALSE POSITIVE RESULT WITH THE BINAX NOW COVID-19 ANTIGEN SELF TEST PERFORMED ON (B)(6) 2022 USING A NASAL SWAB. CONFIRMATION TESTING WAS PERFORMED (B)(6) 2022 WITH A RT PCR TEST AND GENERATED A NEGATIVE RESULT. THE CONSUMER WAS ASYMPTOMATIC. THE CUSTOMER CONFIRMED THERE WAS NO PATIENT HARM DUE TO THE TEST RESULTS. ADDITIONALLY, THE CUSTOMER CONFIRMED THERE WAS NO DELAY OR IMPACT IN THE PATIENT'S TREATMENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2937163 BINAXNOW¿ COVID-19 ANTIGEN SELF TEST LATERAL FLOW IMMUNOASSAY IVD OF COVID-19 QKP ABBOTT DIAGNOSTICS SCARBOROUGH, INC. 202644 00811877011408

Patients

Seq Age Sex Outcome Treatment
1 33 YR Female